The U.S. is ready to roll out the COVID vaccine once it’s approved for kids age 5-11

. Justin Sullivan/Getty Images

toggle caption

Safeway pharmacist Ashley McGee fills a syringe with the Pfizer COVID-19 booster vaccination at a vaccination booster shot center on Oct. 1, in San Rafael, Calif

hide caption

Justin Sullivan/Getty Images

The White House said on Wednesday that it is ready to quickly roll out COVID-19 vaccines for kids ages 5 to 11, if the Pfizer-BioNTech vaccine for that age group is licensed by the Food and Drug Administration and advised by the Centers for Disease Control and Prevention. The administration has actually purchased enough dosages for all 28 million kids because age and will provide it in smaller bundles with important products like smaller sized needles to make it simpler to get to physicians, pediatricians and community university hospital, Biden administration authorities stated. “Should the FDA and CDC authorize the vaccine, we will be prepared to get shots in arms,” stated White House coronavirus action coordinator Jeff Zients during a news rundown Wednesday morning.

. Justin Sullivan/Getty Images

The White House said on Wednesday that it is all set to rapidly roll out COVID-19 vaccines for kids ages 5 to 11, if the Pfizer-BioNTech vaccine for that age group is authorized by the Food and Drug Administration and advised by the Centers for Disease Control and Prevention. The vaccine might be cleared for use in kids ages 5 to 11 within a couple of weeks, officials stated. White House officials said they were revealing the strategy to inoculate children ages 5 to 11 prior to the vaccine was authorized for that age group so they might be “operationally ready” to deploy the doses as quickly as the approval came.

Under the strategy, the administration will work with state and local leaders to make the vaccine readily available at more than 25,000 pediatricians workplaces and primary care websites and 100 kidss health center systems in addition to drug stores, schools and neighborhood university hospital. The administration also will present a national public education project to inform moms and dads and guardians about the vaccine and solicit concerns. U.S. Surgeon General Vivek Murthy said the campaign would help head off one of the barriers to vaccinating both children and grownups– misinformation about the drug. “Thats why were making certain that its relied on messengers with scientific trustworthiness who go out there and speak about these vaccines,” Murthy stated. “But it is our cumulative duty– whether were in federal government, in the media, whether were people– to help prevent the circulation and spread of misinformation online.”

Safeway pharmacist Ashley McGee fills a syringe with the Pfizer COVID-19 booster vaccination at a vaccination booster shot clinic on Oct. 1, in San Rafael, Calif

The vaccine might be cleared for usage in kids ages 5 to 11 within a couple of weeks, authorities said. The FDAs independent advisory committee conference is set up for Oct. 26, and the CDCs independent advisory committee conference is set for Nov. 2 and 3. The Pfizer vaccine currently has full approval for usage in adults, and the federal government has actually authorized it for emergency use in kids ages 12 to 17. White House authorities stated they were announcing the strategy to inoculate kids ages 5 to 11 before the vaccine was approved for that age group so they might be “operationally prepared” to release the doses as soon as the approval came.

Leave a Reply

Your email address will not be published. Required fields are marked *